Suppr超能文献

床边Tenckhoff导管植入经验。

Experiences on bedside Tenckhoff catheter implantation.

作者信息

Sirivongs Dhavee, Praderm Laksamon, Chan-On Chitranon

机构信息

Division of Nephrology, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

J Med Assoc Thai. 2011 Sep;94 Suppl 4:S58-63.

Abstract

OBJECTIVE

To clarify the outcome of a bedside technique of peritoneal dialysis (PD) catheter implantation which is practiced differently from worldwide guidelines in some points.

MATERIAL AND METHOD

This retrospective study was conducted in end stage renal diseases (ESRD) patients treated with chronic ambulatory peritoneal dialysis (CAPD). Catheter placement was initiated by the authors' bedside technique comprising no antibiotic prophylaxis, dry abdomen, and routinely right sided exit site as our protocol. All events within one month postimplantation, such as tip mal-position, malfunction, infection, and bleeding were analyzed.

RESULTS

One hundred and fourteen cases were participated with age, ranged from 14 to 78 yrs. Of the participating subjects, 38.5% was female and 60.52% was diabetes mellitus (DM). After 1 month, 113 out of 114 cases (99.1 %) accomplished CAPD. Of these, 79.8 % had good tip position and function after the break-in period. Early mal-position and poor flow was detected in 21 cases (18.4 %); 9 of them responded to laxative bowel stimulation while 12 cases needed surgical correction. Exit-site infection and/or wound infection were found in 7.9%. The peritonitis rate was 2.63%. All cases with infection were cured. Coagulase positive Staphylococcus aureus was the major causative organism.

CONCLUSION

Bedside Tenckhoff catheter implantation without antibiotic prophylaxis in dry abdomen is a safe modality for selected ESRD patients.

摘要

目的

阐明一种床旁腹膜透析(PD)导管植入技术的结果,该技术在某些方面与全球指南的做法不同。

材料与方法

本回顾性研究纳入了接受持续性非卧床腹膜透析(CAPD)治疗的终末期肾病(ESRD)患者。导管置入采用作者的床旁技术,按照我们的方案,不进行抗生素预防,保持腹部干燥,且常规选择右侧出口部位。分析植入后1个月内的所有事件,如尖端位置不当、功能障碍、感染和出血。

结果

114例患者参与研究,年龄在14至78岁之间。参与研究的受试者中,38.5%为女性,60.52%患有糖尿病(DM)。1个月后,114例中有113例(99.1%)完成了CAPD。其中,79.8%在磨合期后尖端位置良好且功能正常。21例(18.4%)检测到早期位置不当和引流不畅;其中9例对泻药肠道刺激有反应,12例需要手术矫正。出口部位感染和/或伤口感染发生率为7.9%。腹膜炎发生率为2.63%。所有感染病例均治愈。凝固酶阳性金黄色葡萄球菌是主要致病菌。

结论

对于选定的ESRD患者,在干燥腹部不进行抗生素预防的床旁Tenckhoff导管植入是一种安全的方式。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验